Genpact Limited (NYSE:G) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Genpact has a consensus “Hold” rating: Seven of nine analysts rate the stock a hold and two recommend buying it. The average 12-month price target is $39.33, above the reported share price of $33.39.
• Genpact reported quarterly earnings of $1.00 per share on $1.34 billion in revenue, with an 11.04% net margin and 23.34% return on equity. Analysts expect full-year EPS of approximately $3.66.
• The company announced a quarterly dividend of $0.1875, equivalent to $0.75 annually and a 2.2% yield. Institutional investors own 96.03% of Genpact, while an executive recently sold 6,191 shares.

Shares of Genpact Limited (NYSE:G - Get Free Report) have received a consensus recommendation of "Hold" from the nine ratings firms that are presently covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $39.33.

G has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft set a $31.00 price objective on Genpact in a report on Friday, July 10th. Wall Street Zen lowered Genpact from a "buy" rating to a "hold" rating in a research report on Saturday, September 12th. Robert W. Baird lowered their price target on Genpact from $45.00 to $38.00 and set a "neutral" rating for the company in a research note on Tuesday, July 7th. Citigroup upped their price target on Genpact from $32.00 to $36.00 and gave the company a "neutral" rating in a research note on Friday, August 7th. Finally, Susquehanna increased their price target on shares of Genpact from $33.00 to $37.00 and gave the company a "neutral" rating in a research report on Friday, August 7th.

Insiders Place Their Bets

In other Genpact news, SVP Anil Nanduru sold 6,191 shares of the stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $37.03, for a total value of $229,252.73. Following the sale, the senior vice president directly owned 70,253 shares in the company, valued at approximately $2,601,468.59. This trade represents a 8.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.58% of the company's stock.

Institutional Trading of Genpact

A number of large investors have recently made changes to their positions in G. Dimensional Fund Advisors LP grew its stake in Genpact by 12.0% in the first quarter. Dimensional Fund Advisors LP now owns 5,609,641 shares of the business services provider's stock valued at $208,965,000 after acquiring an additional 598,877 shares during the period. Geode Capital Management LLC raised its position in shares of Genpact by 2.6% during the fourth quarter. Geode Capital Management LLC now owns 4,330,116 shares of the business services provider's stock worth $210,391,000 after purchasing an additional 107,870 shares during the period. Franklin Resources Inc. raised its position in shares of Genpact by 3.8% during the fourth quarter. Franklin Resources Inc. now owns 3,508,847 shares of the business services provider's stock worth $164,144,000 after purchasing an additional 129,664 shares during the period. First Trust Advisors LP lifted its holdings in shares of Genpact by 10.2% during the 1st quarter. First Trust Advisors LP now owns 2,415,994 shares of the business services provider's stock valued at $89,996,000 after purchasing an additional 222,899 shares in the last quarter. Finally, Panagora Asset Management Inc. lifted its holdings in shares of Genpact by 62.4% during the 4th quarter. Panagora Asset Management Inc. now owns 967,459 shares of the business services provider's stock valued at $45,258,000 after purchasing an additional 371,814 shares in the last quarter. Institutional investors own 96.03% of the company's stock.

Genpact Price Performance

Shares of G stock opened at $33.39 on Friday. The firm's 50 day moving average price is $34.96 and its two-hundred day moving average price is $33.93. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.00 and a current ratio of 2.00. Genpact has a 52-week low of $26.85 and a 52-week high of $48.64. The stock has a market cap of $5.61 billion, a PE ratio of 9.91, a PEG ratio of 0.90 and a beta of 0.58.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Tuesday, June 30th. The business services provider reported $1.00 EPS for the quarter. The company had revenue of $1.34 billion during the quarter. Genpact had a net margin of 11.04% and a return on equity of 23.34%. As a group, analysts forecast that Genpact will post 3.66 EPS for the current year.

Genpact Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, September 10th were paid a $0.1875 dividend. This represents a $0.75 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Thursday, September 10th. Genpact's dividend payout ratio is presently 22.26%.

Genpact Company Profile

Genpact is a global professional services and technology company that helps organizations transform business processes and improve operational performance. Its services combine artificial intelligence, data and analytics, cloud technologies, digital engineering, and process expertise to support functions such as finance and accounting, procurement, supply chain management, customer care, risk management, and insurance operations.

The company serves clients across industries including banking and capital markets, insurance, healthcare and life sciences, consumer goods and retail, high technology, manufacturing, and professional services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.